Are B vitamins a risk factor for venous thromboembolism? Yes

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 2, 2006, Pages 307-308

  Eichinger, Sabine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PLACEBO; PYRIDOXINE; VITAMIN B GROUP;

ARTICLE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG SAFETY; FOLLOW UP; HUMAN; HYPERHOMOCYSTEINEMIA; LUNG EMBOLISM; MEDICAL RESEARCH; PATIENT CARE; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; TREATMENT FAILURE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; VITAMIN SUPPLEMENTATION; BLOOD; NOTE; PYRIDOXINE DEFICIENCY; RECURRENT DISEASE; THROMBOEMBOLISM; VEIN THROMBOSIS; VITAMIN DEFICIENCY;

HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; RECURRENCE; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS; VITAMIN B 6; VITAMIN B 6 DEFICIENCY; VITAMIN B DEFICIENCY;

EID: 33645575762     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01711.x     Document Type: Article

References (18)

1. Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 1998; 158: 2101-6.
2. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM. Hyperhomocysteinemia and venous thrombosis: A meta-analysis. Thromb Haemost 1998; 80: 874-7.
3. den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies. J Thromb Haemost 2005; 3: 292-9.
4. den Heijer M, Willems H, Blom H, Gerrits WBJ, Cattaneo M, Eichinger S, Rosendaal FR, Bos G. Homocysteine lowering by B vitamins and the secondary prevention of deep-vein thrombosis and pulmonary embolism. A randomised, placebo-controlled, double blind trial. J Thromb Haemost 2005; 3: H03.
5. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens C, Stampfer MJ. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998; 279: 359-64.
6. Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 1997; 20: 295-300.
7. Rinehart JF, Greenberg LD. Pathogenesis of experimental arteriosclerosis in pyridoxine deficiency. Arch Pathol 1951; 51: 12-8.
8. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, Hess DL, Davis CE. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998; 98: 204-10.
9. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, Kottke-Marchant K, Savon SR, Selhub J, Nissen SE, Kutner M, Topol EJ, Jacobsen DW. Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease. Circulation 1995; 92: 2825-30.
10. Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, Rubba P, Palma-Reis R, Meleady R, Daly L, Witteman J, Graham I. Low circulating folate and vitamin B6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease: European COMAC Group. Circulation 1998; 97: 437-43.
11. Bender DA. Novel functions of vitamin B6. Proc Nutr Soc 1994; 53: 625-30.
12. van Wyk V, Luus HG, Heyns AD. The in vivo effect in humans of pyridoxal-5′-phosphate on platelet function and blood coagulation. Thromb Res 1992; 66: 657-68.
13. Saibeni S, Cattaneo M, Vecchi M, Zighetti ML, Lecchi A, Lombardi R, Meucci G, Spina L, de Franchis R. Low vitamin B6 plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: Role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 2003; 98: 112-7.
14. Cattaneo M, Lombardi R, Lecchi A, Bucciarelli P, Mannucci PM. Low plasma levels of vitamin B6 are in dependently associated with a heightened risk of deep-vein thrombosis. Circulation 2001; 104: 2442-6.
15. Eichinger S, Stumpflen A, Hirschl M, Bialonczyk C, Herkner K, Stain M, Schneider B, Pabinger I, Lechner K, Kyrle PA. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost 1998; 80: 566-9.
16. Cattaneo M, Kyrle PA, Lombardi R, Weltermann A, Lecchi A, Eichinger S. Low plasma levels of pyridoxal-5′-phosphate are a risk factor for recurrent venous thromboembolism. Blood 2003; 11: A735.
17. Cattaneo M, Lombardi R, Lecchi A, Bos G, Blom H, Rosendaal F, den Heijer M. Low plasma levels of vitamin B6 and recurrent venous thrombosis: Risk assessment and effect of combined vitamin supplementation in the VITRO-trial. J Thromb Haemost 2005; 3: P1079.
18. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365: 1163-74.